Does a Biopsy — Spread Cancer?

Yes, it is a documented phenomenon — but it is rare, and it is specific to certain cancer types rather than a general risk of all biopsies. It has been reported most in hepatocellular carcinoma and mesothelioma, among others. Oncologists know about it and take steps to minimise it, including the use of co-axial needles that reduce the exposed needle path. For the great majority of patients and cancer types, NCCN and ASCO guidance does not consider this risk a reason to avoid biopsy, because the necessity of a tissue diagnosis outweighs it.

A small sample of tissue is removed — using a needle, a small cutting instrument, or sometimes by removing the whole suspicious area — and sent to a pathologist who examines the cells under a microscope. That examination is how your team confirms whether cancer is present, what type it is, how the cells are behaving, and which treatments are most likely to work. Imaging scans show where and how large; only tissue tells you what.

Scans show what is there and where it is, but they cannot reliably distinguish between cancer types or tell your team which treatments are most likely to work. Two tumours that look identical on a PET-CT can have completely different molecular profiles that need different treatments. Biomarker testing — which decides whether immunotherapy or targeted therapy is an option — requires actual tissue. In almost all cases, a scan result alone is not enough to start treatment.

Their concern comes from wanting to protect you, and it is worth taking seriously rather than dismissing. Ask your oncologist to explain directly — at an appointment your family member attends if possible — what the biopsy is for, what happens if it is not done, and what specific risk applies to your situation. If the concern is about something specific they have read or heard, bring that to the appointment and ask for it to be addressed. Hearing the answer from the treating team carries more weight than reading about it.

Your oncologist cannot force you to have it, and your decision will be respected. What changes is the quality of the information your treatment decisions are based on. Without a tissue diagnosis, your team cannot confirm the cancer type, cannot test for markers that might open treatment options, and may have to treat empirically — according to what is most likely rather than what is confirmed. Some treatments cannot safely be given without a confirmed diagnosis. Your oncologist can explain specifically what would and would not be possible for your situation without one.